Document is current
Any future updates will be listed below
-
Authors
Smith, Eleanor C.
Mott, Bryan T
Douglas, Emily
Tatter, Stephen B.
Watabe, Kounosuke
-
Funding
Funding for this research was provided by:
Wake Forest University School of Medicine, Department of Neurological Surgery
NIH T32 Translational Oncology Training Program
Wake Forest University
- License Information
-
More Information
Article History
Received: 27 June 2024
Accepted: 22 November 2024
First Online: 29 November 2024
Declarations
:
: Dr. Emily Douglas serves on the advisory board of Novartis
